Non-pneumonitis immune-mediated adverse events (imAEs) with durvalumab in patients with unresectable stage III NSCLC (PACIFIC).


Naidoo J., Vansteenkiste J. F., Faivre-Finn C., Ozguroglu M., Murakami S., Hui R., ...Daha Fazla

JOURNAL OF CLINICAL ONCOLOGY, cilt.38, sa.15, 2020 (SCI-Expanded) identifier

  • Yayın Türü: Makale / Özet
  • Cilt numarası: 38 Sayı: 15
  • Basım Tarihi: 2020
  • Dergi Adı: JOURNAL OF CLINICAL ONCOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, PASCAL, CAB Abstracts, CINAHL, EMBASE, Gender Studies Database, International Pharmaceutical Abstracts, MEDLINE, Veterinary Science Database
  • İstanbul Üniversitesi Adresli: Evet